Geneos Wealth Management Inc. Sorrento Therapeutics, Inc. Transaction History

Geneos Wealth Management Inc.

  • $2.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 08, 2021
SELL
$6.35 - $10.0 $113,347 - $178,500
-17,850 Closed
0 $0
Q4 2020

May 19, 2021
BUY
$5.76 - $11.95 $55,929 - $116,034
9,710 Added 119.29%
17,850 $147,000
Q3 2020

Sep 07, 2021
BUY
$6.17 - $18.82 $30,850 - $94,100
5,000 Added 159.24%
8,140 $78,000
Q2 2020

Sep 07, 2021
BUY
$1.73 - $6.76 $5,432 - $21,226
3,140 New
3,140 $18,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email